ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

Brinker Again To Lead Komen As CEO

December 11, 2009

AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed

December 8, 1978

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992